Clinical decision rule for CT imaging in adults with minor head injury (GCS 13–15).
The Canadian CT Head Rule was developed by Ian Stiell and colleagues at the Ottawa Hospital Research Institute. Published in The Lancet in 2001, it was derived from a prospective cohort study of 3,121 patients and subsequently validated.
The rule is designed to identify patients with minor head injury who are at risk of clinically important brain injury requiring neurosurgical intervention (high-risk criteria) or any brain injury visible on CT (medium-risk criteria).
Sensitivity: 100% for neurosurgical intervention, 98.4% for clinically important brain injury. The original derivation study projected a 25–50% relative reduction in CT scan rates; real-world implementation studies since have shown mixed results, with some sites seeing little to no reduction in practice.
Reference: Stiell IG, Wells GA, Vandemheen K, et al. The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001;357(9266):1391-1396. Verified September 2026.
Eye Opening: Spontaneous = 4, To voice = 3, To pain = 2, None = 1
Verbal Response: Oriented = 5, Confused = 4, Inappropriate words = 3, Incomprehensible = 2, None = 1
Motor Response: Obeys commands = 6, Localises pain = 5, Withdrawal = 4, Flexion = 3, Extension = 2, None = 1
Total: 3–15. Minor head injury = GCS 13–15. Moderate = 9–12. Severe = 3–8.
The Canadian CT Head Rule does NOT apply to patients on anticoagulants. Patients taking warfarin, DOACs (apixaban, rivarelbane, dabigatran, edoxaban), or with known bleeding disorders should have a lower threshold for CT head imaging regardless of other criteria.
Many guidelines recommend CT for all anticoagulated patients with head trauma, even if GCS 15 and no other high-risk features, due to the increased risk of delayed intracranial haemorrhage. Consider a period of observation (4–8 hours) even with a normal initial CT in anticoagulated patients.